Loading clinical trials...
Loading clinical trials...
Laser Acupuncture for Idiopathic Bell's Palsy: a Randomized Controlled Trial
Bell's palsy is characterized by acute, unilateral onset that compromises function and esthetics, exerting a considerable impact on the social, professional, and psychological aspects of the lives of affected individuals. The objective of this study was to determine whether laser acupuncture therapy could relieve symptoms in patients with Bell's palsy.
This study was randomized controlled trial including 360 patients that undergoing Bell's palsy. All the patients received oral Prednisolone. Patients were assigned to the laser acupuncture (LA) group, Sham LA group and control group, with 120 patients in each group. LA group and Sham LA group were received 4 weeks of Laser treatment (3 times per week). Clinical outcome measure comprised the House-Brackmann grading system, Sunnybrook facial grading scale (SBFG), Facial Disability Index (FDI) and Facial Clinimetric Evaluation Scale (FaCE Scale) All the measurements were collected at the baseline, weeks 2, 4, 6, 8, 12 and 24.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
China Beijing TongRen Hospital, Capital Medical University Beijing, China
Beijing, Beijing Municipality, China
Start Date
December 1, 2024
Primary Completion Date
May 1, 2026
Completion Date
June 1, 2026
Last Updated
December 13, 2024
360
ESTIMATED participants
Laser acupuncture
DEVICE
Steroids
DRUG
Sham laser acupuncture
DEVICE
Lead Sponsor
Beijing Tongren Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04153916